Inherited Neuropathies Consortium
More than 40 scientists and physicians from North America, Europe and Australia gathered in Miami on January 28-30, 2016 for the Inherited Neuropathies Consortium (INC) meeting. The INC is dedicated to conducting clinical, genetic, and basic research in different forms of Charcot-Marie-Tooth (CMT) disease, a disorder that affects the peripheral nerves. There are currently 17 active recruitment and research sites in North America, Europe and Australia with additional sites being added.
The meeting was hosted by the local team of investigators, led by Drs. Mario Saporta and Stephan Zuchner, from the University of Miami Miller School of Medicine. The conference’s speakers presented on a variety of topics ranging from pediatrics to late onset neuropathies with the goal of identifying the causes and possible treatments for peripheral neuropathies. The collaborations are made possible through awards by the National Institutes of Health (NIH) to expand the Rare Diseases Clinical Research Network (RDCRN). Established in 2003 by the NIH Office of Rare Diseases, the RDCRN is designed to advance medical research on rare diseases by facilitating collaboration, study enrollment and data sharing.
The University of Miami is a proud founding member of the consortium and is housing all INC-funded genetic studies as well as a new patient enrollment center, directed by Dr. Mario Saporta, MD, PhD, Assistant Professor of Neurology and Human Genetics.
The INC principal investigators were thankful to the local organizing team and for support from NIH, Charcot-Marie-Tooth Association (CMTA), The Genesis Project, and the University of Miami.